Stein Mitchell Represents Whistleblowers in Nearly $385 Million Abbott Infant Formula Settlement

Stein Mitchell Beato & Missner LLP has represented three former Abbott Laboratories employees in a settlement totaling nearly $385 million. The resolution addresses allegations of substandard manufacturing practices in the production of infant formula. The law firm initially filed the complaint in 2022.

This case is notable for its use of the False Claims Act, a federal law designed to combat fraud against the government. The allegations centered on purported manufacturing defects that could have compromised product safety and potentially led to fraudulent claims submitted to federal programs.

While specific terms of the settlement have not been fully disclosed, the outcome underscores the critical role of whistleblowers in corporate oversight and the exposure of potential misconduct. The act allows whistleblowers to receive a portion of the recovered funds.

Abbott Laboratories is a global healthcare company that produces a wide range of products, including infant nutrition, medical devices, and diagnostics. Its operations are subject to significant regulatory scrutiny, particularly concerning product safety and manufacturing standards.